DCGO News & Events

Reports Q1 revenue $75.6M, consensus $72.4M. Lee Bienstock, Chief Executive Officer of DocGo, commented, "We continued to experience strong volumes across all key business verticals, and especially in our virtual care provider, SteadyMD. We now expect in excess of 50% top-line growth this year at SteadyMD compared to 2025, and even greater growth in our mobile phlebotomy business. As a result of this strength, we are increasing our consolidated 2026 revenue guidance midpoint by $7.5 million dollars." Bienstock added, "Our strategic alternatives process is also ongoing, and we look forward to providing further updates when prudent."

Reports Q4 revenue $74.9M, consensus $70.4M. Lee Bienstock, Chief Executive Officer of DocGo, commented "While 2025 was a year of transition and focus on our core business lines, the robust growth in our 'healthcare at any address' business - which includes care in the home, remote patient monitoring, mobile phlebotomy and virtual care services - supports our belief that DocGo's offering is well positioned to meet the needs of the evolving healthcare landscape." Bienstock continued "We are increasing guidance based on the record volumes we've seen thus far in 2026, and the anticipated full-year impact of our cost efficiency initiatives. We believe that our plan and resources are sufficient to enable the Company to achieve profitability in the second half of 2026."